In the last trading session, 1.32 million Pliant Therapeutics Inc (NASDAQ:PLRX) shares changed hands as the company’s beta touched 1.48. With the company’s per share price at $1.54 changed hands at $0.02 or 1.32% during last session, the market valuation stood at $94.30M. PLRX’s last price was a discount, traded about -972.73% off its 52-week high of $16.52. The share price had its 52-week low at $1.26, which suggests the last value was 18.18% up since then. When we look at Pliant Therapeutics Inc’s average trading volume, we note the 10-day average is 4.69 million shares, with the 3-month average coming to 2.42 million.
Analysts gave the Pliant Therapeutics Inc (PLRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.69. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended PLRX as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Pliant Therapeutics Inc’s EPS for the current quarter is expected to be -0.76.
Pliant Therapeutics Inc (NASDAQ:PLRX) trade information
Instantly PLRX was in green as seen at the end of in last trading. With action -4.94%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -88.31%, with the 5-day performance at -4.94% in the red. However, in the 30-day time frame, Pliant Therapeutics Inc (NASDAQ:PLRX) is -43.38% down. Looking at the short shares, we see there were 3.29 million shares sold at short interest cover period of 0.93 days.
The consensus price target for the stock as assigned by Wall Street analysts is 2.5, meaning bulls need an upside of 38.4% from its current market value. According to analyst projections, PLRX’s forecast low is 2 with 3 as the target high. To hit the forecast high, the stock’s price needs a -94.81% plunge from its current level, while the stock would need to soar -29.87% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -78.30%. The 2025 estimates are for Pliant Therapeutics Inc earnings to increase by 23.30%, but the outlook for the next 5-year period is at 15.87% per year.
PLRX Dividends
Pliant Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Mar-02.
Pliant Therapeutics Inc (NASDAQ:PLRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.27% of Pliant Therapeutics Inc shares while 117.06% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 121.02%. There are 117.06% institutions holding the Pliant Therapeutics Inc stock share, with DEEP TRACK CAPITAL, LP the top institutional holder. As of 2024-06-30, the company held 9.8907% of the shares, roughly 5.97 million PLRX shares worth $64.2 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.2612% or 4.97 million shares worth $53.45 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund . With 2.34 shares estimated at $3.6 million under it, the former controlled 3.82% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.92% of the shares, roughly 1.79 shares worth around $2.76 million.
